Vimarsana
Biggest News Aggregation in the World

Page 2 - Study Findings News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Findings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Findings Today - Breaking & Trending Today

Collier leaders sticking with district-only elections; reject study to look at pros and cons - Vimarsana News

Collier leaders sticking with district-only elections; reject study to look at pros and cons

Collier County switched in 1988 to single district elections for Collier County Commission. Does growth justify going back to countywide elections?

Source: yahoo.com
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors - Vimarsana News

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors

Published data shows lymph node-targeted Amphiphile -peptide and CpG combination with TCR-T cell therapy led to complete eradication and durable responses against established murine solid tumors...

Dementia among younger people is linked to 15 factors, major study reveals - Vimarsana News

Dementia among younger people is linked to 15 factors, major study reveals

Early-onset dementia has been on the rise in recent years — and a major new study has identified 15 factors that could increase the risk. The lead researcher and an Alzheimer's expert weigh in.

Source: yahoo.com
Is It Idiopathic Hypersomnia or Narcolepsy? Brain Imaging May Hold Answers - Vimarsana News

Is It Idiopathic Hypersomnia or Narcolepsy? Brain Imaging May Hold Answers

Brain imaging research identifies differences in brain structure and activity that could help in understanding and distinguishing IH.

Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting - Vimarsana News

Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vaccine, as monotherapy, 87% had direct ex vivo...